|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910786222803321 |
|
|
Autore |
Barnett A. H (Anthony H.), <1951-> |
|
|
Titolo |
New mechanisms in glucose control [[electronic resource] /] / Anthony H. Barnett, Jenny Grice |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Chichester, West Sussex, : Wiley-Blackwell, 2011 |
|
|
|
|
|
|
|
ISBN |
|
1-118-68218-1 |
1-299-46883-7 |
1-118-68220-3 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (74 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Type 2 diabetes |
Hypoglycemic agents |
Obesity - Surgery |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Epidemiology and pathogenesis of type 2 diabetes -- Overview of current diabetes management -- The incretin system -- The incretin mimetics -- Dipeptidyl peptidase-4 inhibitors -- Sodium-glucose cotransporter-2 inhibitors -- Pipeline diabetes therapies -- Bariatric surgery for the treatment of type 2 diabetes -- Organization of diabetes care. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
New Mechanisms in Glucose Control presents a clear overview of the new drugs and treatment therapies that have been developed in recent years to help improve glycaemic management for the diabetic patient, namely the incretin mimetics (GLP-1 agonists) and DPP-4 inhibitors. It also considers other drug classes currently in development and undergoing clinical trials including the SGLT2 inhibitors and other pipeline products. In addition to pharma cotherapeutic agents, the role of bariatric as a management tool for diabetes is covered as well as consideration of the organisation of diabete |
|
|
|
|
|
|
|